The fund is also close to making an investment in Fanatics, the online sports apparel retailer, according to people briefed on the plans . Roivant, founded in 2014, is headquartered in Basel, Switzerland, but has the majority of its operations in the US.
Filing activity remained muted with one Chinese luxury e-commerce company, two micro-cap healthcare deals, and two tech-focused SPACs joining the pipeline, while another mico-cap biotech withdrew. With the "active pipeline" at just 32 IPOs, the ... Led.
The rights plan may also be terminated prior to its scheduled expiration. Ronald A. Rittenmeyer, Executive Chairman Mr. Rittenmeyer previously served as lead director at Tenet, and has been a Tenet Board member since 2010. He previously served as chairman.
Amgen to open Capability Center in Tampa Florida Trend.
But having run preclinical tests of topical and intradermal formulations of KB103 and met with the FDA late last year, it plans to embark on a whistle-stop development program. The plan is to file an IND in the first ... The early-stage nature of.
All the planning is meaningless if we don't follow through."-Mark Avallone, president of Potomac Wealth Advisors and author of "Countdown to Financial Freedom" To ... said Tom Harris, an executive vice president at Penn Mutual Life Insurance.
Trump invites Vertex CEO to White House for biotech summit Boston Business Journal.
In addition, world renowned leaders joined the Company (i.e KOLs from Harvard Medical school, executives from Pfizer and Merck) and the Company teamed up with Boston based Locust-Walk business development group for planning and launching a .
ValuEngine - Stock and Industry Analysis Reports, Daily Technical Portfolio Stock and Industry Analysis Reports, Daily Technical Portfolio.
Aeterna Zentaris Inc. - AEZS - Stock Price Today - Zacks Zacks Investment Research.
August 31, 2017 16:05 ET | Source: Conatus Pharmaceuticals Inc. SAN DIEGO, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology ... M.B.A., as Executive Vice President, Chief Operating Officer and Chief Financial.
16, 2017 (GLOBE NEWSWIRE) -- Monsanto Company (NYSE:MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced today that the companies have reached a global licensing agreement for the use of ... Certain.